Automated Breast Ultrasound Systems Market Trend, Share, Growth, Size, Analysis and Forecast 2030

Table Of Content

Methodology

Free Analysis

Automated breast ultrasound system (ABUS) captures ultrasound images of the breasts through a transducer, which helps in scanning the whole breast. It also provides 3D images of dense breast tissues for cancer detection. Automated breast ultrasound inspection offers benefits including 3D images and coronal view, less turnaround time, and improved diagnostics solutions. Key companies, such as Siemens Healthcare, SonoCine, and U-Systems Inc., have developed an automated breast ultrasound system, the latest technology, as a substitute for conventional hand-held ultrasounds for supplemental use. Some automated breast ultrasound systems take only seven minutes to perform a bilateral exam, which is half the time taken by traditional ultrasound systems. An automated breast ultrasound system contains a transducer without human intervention and it scans the breast, which reduces operator dependency. This is a user-friendly system, with a touchscreen, intelligent imaging algorithms, a transducer shaped for a woman’s anatomy, and automated compression, that provides efficient reading and analysis.

According to the World Health Organization (WHO), breast cancer is the most widespread cancer among women globally. Breast cancer is the second foremost reason for death among women across the globe. As per National Breast Cancer Foundation statistics, it is projected that in the U.S., each year nearly 252,710 women are diagnosed with breast cancer and approximately 40,500 women die. In the U.S., one in eight women is diagnosed with breast cancer. Even though breast cancer in men is less frequent, an estimated 2,470 men are diagnosed with breast cancer and approximately 460 die each year. More than 3.3 million people are living with breast cancer in the U.S. alone today. The automated breast ultrasound systems market is growing rapidly due to the increase in breast cancer cases among women and increased number of women undergoing breast cancer screening. Additionally, availability of funds to install relatively expensive ABUSis likely to support the automated breast ultrasound systems market. However, the high cost of automated breast ultrasound systems might be a restraint for market growth. Additionally, lengthy test durations and a shortage of trained and skilled specialists and professionals for operating the tools can hamper this market’s growth. Growing incidences of breast cancer witnessed across the globe is anticipated to generate lucrative opportunities for the automated breast ultrasound systems market in the future.

The automated breast ultrasound systems market is divided based on product, application, and end-user. By product, the automated breast ultrasound systems market is categorized into an automated breast ultrasound system and automated breast volume scanner. The automated breast ultrasound system (ABUS) segment is projected to dominate in the future, due to the advantages like uniformity, high reproducibility, and high-resolution images. Thus, this segment is likely to contribute significantly toward business growth in this market. By application, the automated breast ultrasound systems market is bifurcated into screening and pre-operative evaluation. By end-user, the automated breast ultrasound systems market is divided into hospitals, ambulatory surgical units, and diagnostic centers.

By geography, North America dominates the global automated breast ultrasound systems market due to the growing rate of breast cancer and favorable regulatory policies. In the U.S., the increased number of women undergoing breast screening has resulted in the expansion of the automated breast ultrasound systems market. In the Asia Pacific region, ever-increasing awareness toward identifying breast cancer at the primary stage and high expenditure related to research and development activities to upgrade technologies for accurate results are driving the market across this region. Japan, China, and India have displayed positive growth for this market across the Asia Pacific region. Latin America is another important regional market and is estimated to register moderate growth in the future, due to the rising presence of hospitals and diagnostic centers for breast cancers and increasing awareness about breast cancer among the people. The Middle East and Africa market are anticipated to witness a significant growth in the forecast timeframe.

Some key players in the automated breast ultrasound systems marketincludeKoninklijke Philips N.V, Siemens AG, SonoCine. Inc., iVu Imaging Corporation, Hitachi Ltd., General Electric Company, Delphinus Medical Technologies, Inc., and Hitachi, Ltd., among others.